MediShield report: Panel of oncologists to look into high cost of cancer drugs
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
CHEMOTHERAPY claims have risen significantly for MediShield Life, and what is worrying is that the cost of cancer drugs in Singapore is also markedly higher than some places in the region.
The MediShield Life Council will appoint a committee of oncologists to "review the coverage of cancer drugs, so that they can be covered in a more sustainable manner''.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
New CPF life-cycle investment scheme could channel up to S$9 billion a year into Singapore stocks: Citi
Middle East-linked energy supply shocks put Asean Power Grid back in focus
SGX RegCo proposes tighter disclosures on pay, dividends and investor relations to lift valuations
What’s behind the Singdollar’s strength amid the Iran war – and how long will it last?
